Bone mineral density in transfusion-dependent thalassemia patients and its associated factors in Southern Iran

被引:8
|
作者
Bordbar, Mohammadreza [1 ]
Omrani, Gholamhossein Ranjbar [2 ]
Haghpanah, Sezaneh [1 ]
Saki, Forough [2 ]
Karimi, Mehran [1 ]
Zekavat, Omidreza [1 ]
机构
[1] Shiraz Univ Med Sci, Hematol Res Ctr, Shiraz, Iran
[2] Shiraz Univ Med Sci, Shiraz Endocrinol & Metab Res Ctr, Shiraz, Iran
关键词
Bone mineral density; Thalassemia; Iran; Endocrinopathy; Cholecystectomy; Splenectomy; VITAMIN-D DEFICIENCY; BETA-THALASSEMIA; DIABETES-MELLITUS; ADULT PATIENTS; OSTEOPOROSIS; DISEASE; HYPOGONADISM; PREVALENCE; FRACTURES; INSIGHTS;
D O I
10.1007/s11657-020-00811-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite the significant improvements in the management of thalassemia, there are growing concerns regarding their long-term complications. We showed that low bone mass is one of the most prevalent complications among these patients. Insufficient physical activity and hypogonadism are the main possible associated factors followed by DM and insufficient sun exposure. Purpose Despite the significant improvements in the management of transfusion-dependent thalassemia (TDT), there are growing concerns regarding their long-term complications. Methods This cross-sectional study included 615 TDT patients who were registered and followed in a comprehensive thalassemia clinic in Southern Iran. We measured serum biochemical tests and bone mineral density in all patients. We recorded physical activity and sun exposure subjectively, and an endocrinologist visited and examined all the patients. A group of age- and gender-matched healthy volunteers participated in the study as the control group. Results The mean age of the studied population was 28.4 +/- 7.7 years, and 55.8% were female. The prevalence of vitamin D deficiency was 45.6% and 54.4% in TDT patients and the control group. A portion of TDT patients suffered from different endocrinopathies, which included hypogonadism (49.8%), diabetes mellitus (17.2%), hypoparathyroidism (14.6%), and hypothyroidism (6.3%). The prevalence of low bone mass in patients with TDT was 48.3 and 74.6% in the femoral and lumbar bones, respectively. Low physical activity, insufficient sun exposure, diabetes mellitus, and hypogonadism were associated with low bone mass. Conclusion Low bone mass is highly prevalent among TDT patients in Southern Iran. Insufficient physical activity and hypogonadism are the main possible associated factors, followed by DM and insufficient sun exposure.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Metabolic Bone Disease in Children With Transfusion-Dependent Thalassemia
    Handattu, Koushik
    Aroor, Shrikiran
    Kini, Pushpa
    Ramesh Bhat, Y.
    Shivakumar, Gayathri
    Shastry, Praveen
    Shetty, Sahana
    INDIAN PEDIATRICS, 2022, 59 (12) : 920 - 923
  • [22] Metabolic Bone Disease in Children With Transfusion-Dependent Thalassemia
    Koushik Handattu
    Shrikiran Aroor
    Pushpa Kini
    Y Ramesh Bhat
    Gayathri Shivakumar
    Praveen Shastry
    Sahana Shetty
    Indian Pediatrics, 2022, 59 : 920 - 923
  • [23] Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
    Thompson, A. A.
    Walters, M. C.
    Kwiatkowski, J.
    Rasko, J. E. J.
    Ribeil, J. -A.
    Hongeng, S.
    Magrin, E.
    Schiller, G. J.
    Payen, E.
    Semeraro, M.
    Moshous, D.
    Lefrere, F.
    Puy, H.
    Bourget, P.
    Magnani, A.
    Caccavelli, L.
    Diana, J. -S.
    Suarez, F.
    Monpoux, F.
    Brousse, V.
    Poirot, C.
    Brouzes, C.
    Meritet, J. -F.
    Pondarre, C.
    Beuzard, Y.
    Chretien, S.
    Lefebvre, T.
    Teachey, D. T.
    Anurathapan, U.
    Ho, P. J.
    von Kalle, C.
    Kletzel, M.
    Vichinsky, E.
    Soni, S.
    Veres, G.
    Negre, O.
    Ross, R. W.
    Davidson, D.
    Petrusich, A.
    Sandler, L.
    Asmal, M.
    Hermine, O.
    De Montalembert, M.
    Hacein-Bey-Abina, S.
    Blanche, S.
    Leboulch, P.
    Cavazzana, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (16): : 1479 - 1493
  • [24] Ocular manifestations in patients with transfusion-dependent β-thalassemia
    Akritidou, F.
    Praidou, A.
    Papamitsou, T.
    Kozobolis, V
    Labiris, G.
    HIPPOKRATIA, 2021, 25 (02) : 79 - 82
  • [25] Bayesian spatial modeling of transfusion-dependent β-thalassemia incidence rate in Fars Province, Southern Iran
    Haghpanah, Sezaneh
    Asmarian, Naeimehossadat
    Zekavat, Omid Reza
    Bordbar, Mohammadreza
    Karimi, Mehran
    Zareifar, Soheila
    Ramzi, Mani
    Safaei, Sanaz
    SPATIAL AND SPATIO-TEMPORAL EPIDEMIOLOGY, 2021, 36
  • [26] Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
    Bordbar, Mohammad Reza
    Silavizadeh, Samir
    Haghpanah, Sezaneh
    Kamfiroozi, Roza
    Bardestani, Marzieh
    Karimi, Mehran
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (06)
  • [27] Delayed Physical Growth and Related Factors in Pediatric Patients with Transfusion-Dependent Thalassemia
    Zhao, Jingyu
    Yu, Xiao
    Xu, Jing
    Gao, Zhen
    Liu, Yanjie
    Wang, Anni
    Dong, Jin
    Yuan, Weiping
    Shi, Jun
    Kuang, Zhexiang
    BLOOD, 2024, 144 : 2307 - 2307
  • [28] Quality of Life and Related Paraclinical Factors in Iranian Patients with Transfusion-Dependent Thalassemia
    Khodashenas, Mehran
    Mardi, Parham
    Taherzadeh-Ghahfarokhi, Nooshin
    Tavakoli-Far, Bahareh
    Jamee, Mahnaz
    Ghodrati, Niloofar
    JOURNAL OF ENVIRONMENTAL AND PUBLIC HEALTH, 2021, 2021
  • [29] Effect of the Hydoxyurea in Yemeni Transfusion-Dependent β-Thalassemia Patients
    Al-Nood, Hafiz A.
    Al-Nood, Rasha M.
    Ghanem, Najeeb S.
    Al-Hadi, Abdulrahman M.
    HEMOGLOBIN, 2020, 44 (02) : 104 - 108
  • [30] Pulmonary dysfunction in transfusion-dependent patients with thalassemia major
    Carnelli, V
    D'Angelo, E
    Pecchiari, M
    Ligorio, M
    D'Angelo, E
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (02) : 180 - 184